Business
Currency:USD
2024/FY
Stock NameRevenueRatio
Therapeutics16.18M86.43%
Contract research15.96M85.24%
Intersegment Elimination-13.42M-71.67%
Region
Currency:USD
2024/FY
Stock NameRevenueRatio
United States18.72M100.00%